Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02358473 · ClinicalTrials.gov registry record · Phase 1
Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer
A Phase 1 study of Non-Small Cell Lung Cancer, sponsored by Kyowa Kirin.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
- 5
- Study locations
NCT02358473: Completed Phase 1 study of Non-Small Cell Lung Cancer, sponsored by Kyowa Kirin.
NCT02358473 is a Phase 1 study of Non-Small Cell Lung Cancer that has completed, run by Kyowa Kirin. The registered enrollment target is 13 participants, below the 652-participant average among 454 other Non-Small Cell Lung Cancer trials with a reported enrollment target (98% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02358473, a Phase 1 study of Non-Small Cell Lung Cancer, has completed, sponsored by Kyowa Kirin.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to evaluate the safety of mogamulizumab in combination with docetaxel in adult subjects with previously treated locally advanced or metastatic non-small cell lung cancer.
Conditions Studied
Interventions
- DRUG Docetaxel
- BIOLOGICAL mogamulizumab
Study Locations (5)
Texas
- MD Anderson - Houston
- Cancer Therapy and Research Center - San Antonio
Indiana
- Horizon Oncology - Lafayette
Maryland
- John Hopkins University School of Medicine - Baltimore
Ohio
- Gabrail Cancer Center Research - Canton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-12 |
| Phase | Phase 1 |
What the finished NCT02358473 record still lists
NCT02358473 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 652-participant average among 454 other Non-Small Cell Lung Cancer trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Non-Small Cell Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Docetaxel is the first listed.
NCT02358473 lists 5 locations in 4 states (Texas, Indiana, Maryland).
Frequently Asked Questions
What is clinical trial NCT02358473 about?
NCT02358473 is a clinical study titled "Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer". The purpose of this study is to evaluate the safety of mogamulizumab in combination with docetaxel in adult subjects with previously treated locally advanced or metastatic non-small cell lung cancer.
What is the current status of trial NCT02358473?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2015-01. Estimated completion is 2016-12.
What conditions does trial NCT02358473 study?
This clinical trial studies the following conditions: Non-Small Cell Lung Cancer.
What interventions are being tested in trial NCT02358473?
The interventions under investigation include: Docetaxel (DRUG), mogamulizumab (BIOLOGICAL).
Who is sponsoring clinical trial NCT02358473?
This trial is sponsored by Kyowa Kirin, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02358473 being conducted?
This trial has 5 study locations across Indiana, Maryland, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-Small Cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02358473's enrollment target sits among peer trials
13 434th of 454 higher than 19 of 454 other Non-Small Cell Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Non-Small Cell Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RECRUITING · Phase 1
-
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
RECRUITING · Phase 1
-
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
RECRUITING · Phase 1
-
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
RECRUITING · Phase 1
-
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia